From Deseret News archives:

Cancer drug may double as an arthritis treatment

Published: Wednesday, March 1, 2006 9:50 p.m. MST
 |  E-MAIL | PRINT | FONT + - 
WASHINGTON (AP) — The nation's best-selling cancer drug has won federal approval as a treatment for rheumatoid arthritis patients for whom other, older drugs don't work, Genentech Inc. and Biogen Idec Inc. said Wednesday.

The Food and Drug Administration action comes more than eight years after the agency initially approved Rituxan to treat non-Hodgkin's lymphoma.

The two companies said Rituxan should be used by patients who haven't had success with a class of rheumatoid arthritis drugs called tumor necrosis factor, or TNF, blockers. Those drugs include Enbrel, Remicade and Humira.

Comments

You can be the first to comment on this story.

previousnext

Latest comments

This is the bowl game for both schools this year - I guess we know how this...

SLCC athletics winning with locals

Holmstead was easily one of the top 3 female players (and arguably THE best)...

NBA roundup: Celts win in OT

Any loss for the Knicks is a great thing this year since the Jazz will be...

Bronco, Kyle rubber match

What's the argument?? Where was Utah in those polls? The only argument the...

Crimes up against gays, religion

"Us liberals aren't into moral relativism." Ummm; It is my expereince...

Glenn Beck to enter politics?

I am in full support of Glen Beck's decision to enter politics. I welcome...

It is funny how those who are critics of the Church feel we as Church members...

Reagan much-beloved in Utah

I'm sorry, but I don't buy the logic you posit about Utah being liberal. No...

It’s absolutely embarrassing to read the vitriolic and malicious...

UTOPIA seeking stimulus funding

UTOPIA is not a private corporation, it is an interlocal entity owned and...

Advertisements